...
首页> 外文期刊>The Journal of Physiology >GABAB receptor transduction mechanisms, and cross-talk between protein kinases A and C, in GABAergic terminals synapsing onto neurons of the rat nucleus basalis of Meynert.
【24h】

GABAB receptor transduction mechanisms, and cross-talk between protein kinases A and C, in GABAergic terminals synapsing onto neurons of the rat nucleus basalis of Meynert.

机译:GABA能受体终端中的GABA B受体转导机制以及蛋白激酶A和C之间的串扰突触到Meynert大鼠核基础神经元上。

获取原文
获取原文并翻译 | 示例
           

摘要

The transduction mechanisms underlying presynaptic GABAB receptor-mediated inhibition of transmitter release have been characterized for a variety of synapses in the central nervous system (CNS). These studies have suggested a range of transduction mechanisms, including a role for second messengers such as protein kinases A (PKA) and C (PKC). In the present study, we have examined the intracellular signalling pathways underlying baclofen-induced inhibition of GABA release from terminals synapsing onto rat basalis of Meynert neurons using patch-clamp recordings. Baclofen, a selective GABAB receptor agonist, reversibly decreased both evoked and spontaneous, miniature, GABAergic inhibitory postsynaptic currents (eIPSCs and mIPSCs, respectively). Such baclofen actions were completely abolished by CGP55845A, a selective GABAB receptor antagonist, and by staurosporine, a non-selective PKA and PKC inhibitor. The mIPSC frequency was still decreased by baclofen even in the presence of 4 AP, a K+ channel blocker, and Cd2+, a voltage-dependent calcium channel blocker. Pharmacological activation or inhibition of PKC activity affected basal GABA release and mildly affected the response to baclofen. Inhibition of the cAMP/PKA cascade also affected basal GABA release and, in a subset of neurons, occluded the effects of baclofen, suggesting that the GABAB receptor-mediated inhibitory action on GABA release was mediated via decreases in PKA activity. In addition, PKA inhibition occluded the effects of PKC modulation on both basal GABA release and on the response to baclofen. Our results characterize the transduction pathway of baclofen at these nucleus basalis of Maynert (nBM) synapses and show, for the first time, some cross-talk between the cAMP/PKA and PKC pathways in mammalian presynaptic nerve terminals.
机译:突触前GABA B受体介导的递质释放抑制的转导机制已针对中枢神经系统(CNS)的各种突触进行了表征。这些研究提出了一系列的转导机制,包括第二信使的作用,例如蛋白激酶A(PKA)和C(PKC)。在本研究中,我们使用膜片钳记录检查了巴氯芬诱导的抑制GABA从末端突触到Meynert神经元大鼠基底上的细胞内信号传导通路。 Baclofen,一种选择性的GABA B受体激动剂,可逆地降低了诱发的和自发的微型GABA能抑制突触后电流(分别为eIPSC和mIPSC)。选择性的GABA B受体拮抗剂CGP55845A和非选择性的PKA和PKC抑制剂星形孢菌素完全消除了这种巴氯芬的作用。即使存在4AP(K +通道阻滞剂)和Cd2 +(电压依赖性钙离子通道阻滞剂)的存在,巴氯芬仍会降低mIPSC频率。药理学激活或抑制PKC活性会影响基础GABA的释放,并轻度影响对巴氯芬的反应。对cAMP / PKA级联的抑制也影响了基础GABA的释放,并且在一部分神经元中阻断了巴氯芬的作用,这表明GABAB受体介导的对GABA释放的抑制作用是通过PKA活性的降低来介导的。此外,PKA的抑制作用阻止了PKC调节对基础GABA释放和对巴氯芬的反应的影响。我们的研究结果表征了在Maynert突触的这些核基底基底上巴氯芬的转导途径,并首次显示了哺乳动物突触前神经末梢中cAMP / PKA和PKC途径之间的串扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号